AnaptysBio, Inc. (ANAB)
66.14
+4.13
(+6.66%)
USD |
NASDAQ |
Mar 11, 12:54
AnaptysBio Total Assets (Quarterly) : 364.40M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 301.35M |
| Rigel Pharmaceuticals, Inc. | 560.62M |
| Vanda Pharmaceuticals, Inc. | 488.95M |
| Esperion Therapeutics, Inc. | 465.89M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 327.18M |
| Shareholders Equity (Quarterly) | 37.21M |
| Debt to Equity Ratio | 7.811 |
| Current Ratio | 9.068 |
| Net Debt Paydown Yield | 1.13% |